Diabetes -- Table of Contents (February 1999, 48 [2])

Articles:

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes: SE Kahn, S Andrikopoulos, and CB Verchere
Diabetes 1999 48: 241-253. [Abstract] [PDF]

Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma: M Wang, SC Wise, T Leff, and TZ Su
Diabetes 1999 48: 254-260. [Abstract] [PDF]

Renal glucose production during insulin-induced hypoglycemia in humans: E Cersosimo, P Garlick, and J Ferretti
Diabetes 1999 48: 261-266. [Abstract] [PDF]

Altered energy balance causes selective changes in melanocortin-4(MC4-R), but not melanocortin-3 (MC3-R), receptors in specific hypothalamic regions: further evidence that activation of MC4-R is a physiological inhibitor of feeding: JA Harrold, PS Widdowson, and G Williams
Diabetes 1999 48: 267-271. [Abstract] [PDF]

Regulation of ob gene expression and leptin secretion by insulin and dexamethasone in rat adipocytes: RL Bradley and B Cheatham
Diabetes 1999 48: 272-278. [Abstract] [PDF]

Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation: S Uotani, C Bjorbaek, J Tornoe, and JS Flier
Diabetes 1999 48: 279-286. [Abstract] [PDF]

Microinjection of leptin into the ventromedial hypothalamus increases glucose uptake in peripheral tissues in rats: Y Minokoshi, MS Haque, and T Shimazu
Diabetes 1999 48: 287-291. [Abstract] [PDF]

Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting: K Ekberg, BR Landau, A Wajngot, V Chandramouli, S Efendic, H Brunengraber, and J Wahren
Diabetes 1999 48: 292-298. [Abstract] [PDF]

Cellular immune responses against proinsulin: no evidence for enhanced reactivity in individuals with IDDM: T Ellis, E Jodoin, E Ottendorfer, P Salisbury, JX She, D Schatz, and MA Atkinson
Diabetes 1999 48: 299-303. [Abstract] [PDF]

Genes expressed during the differentiation of pancreatic AR42J cells into insulin-secreting cells: H Mashima, S Yamada, T Tajima, M Seno, H Yamada, J Takeda, and I Kojima
Diabetes 1999 48: 304-309. [Abstract] [PDF]

Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle: YB Kim, JS Zhu, JR Zierath, HQ Shen, AD Baron, and BB Kahn
Diabetes 1999 48: 310-320. [Abstract] [PDF]

Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects: JM Gibson, M Westwood, FF Lauszus, JG Klebe, A Flyvbjerg, and A White
Diabetes 1999 48: 321-326. [Abstract] [PDF]

13C nuclear magnetic resonance study of glycogen resynthesis in muscle after glycogen-depleting exercise in healthy men receiving an infusion of lipid emulsion: MC Delmas-Beauvieux, B Quesson, E Thiaudiere, JL Gallis, P Canioni, and H Gin
Diabetes 1999 48: 327-333. [Abstract] [PDF]

High-fat meals reduce 24-h circulating leptin concentrations in women: PJ Havel, R Townsend, L Chaump, and K Teff
Diabetes 1999 48: 334-341. [Abstract] [PDF]

Hepatic glucose cycling does not contribute to the development of hyperglycemia in Zucker diabetic fatty rats: DC Henly, MC Chauvet, and JW Phillips
Diabetes 1999 48: 342-346. [Abstract] [PDF]

Plasma leptin and insulin levels in weight-reduced obese women with normal body mass index: relationships with body composition and insulin: S Guven, A El-Bershawi, GE Sonnenberg, CR Wilson, RG Hoffmann, GR Krakower, and AH Kissebah
Diabetes 1999 48: 347-352. [Abstract] [PDF]

An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats: P Faure, E Rossini, N Wiernsperger, MJ Richard, A Favier, and S Halimi
Diabetes 1999 48: 353-357. [Abstract] [PDF]

Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in humans: M Roden, M Krssak, H Stingl, S Gruber, A Hofer, C Furnsinn, E Moser, and W Waldhausl
Diabetes 1999 48: 358-364. [Abstract] [PDF]

Induction of obesity and hyperleptinemia by central glucocorticoid infusion in the rat: KE Zakrzewska, I Cusin, A Stricker-Krongrad, O Boss, D Ricquier, B Jeanrenaud, and F Rohner-Jeanrenaud
Diabetes 1999 48: 365-370. [Abstract] [PDF]

Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo: AT Lee, D Reis, and UJ Eriksson
Diabetes 1999 48: 371-376. [Abstract] [PDF]

Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice: A Flyvbjerg, WF Bennett, R Rasch, JJ Kopchick, and JA Scarlett
Diabetes 1999 48: 377-382. [Abstract] [PDF]

Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group: Diabetes 1999 48: 383-390. [Abstract] [PDF]

Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide: A Avogaro, L Calo, F Piarulli, M Miola, S deKreutzenberg, A Maran, A Burlina, R Mingardi, A Tiengo, and S Del Prato
Diabetes 1999 48: 391-397. [Abstract] [PDF]

A sib-pair analysis study of 15 candidate genes in French families with morbid obesity: indication for linkage with islet 1 locus on chromosome 5q: K Clement, C Dina, A Basdevant, N Chastang, V Pelloux, N Lahlou, M Berlan, D Langin, B Guy-Grand, and P Froguel
Diabetes 1999 48: 398-402. [Abstract] [PDF]

Mutational analysis of the coding regions of the genes encoding protein kinase B-alpha and -beta, phosphoinositide-dependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase inhibitor-1, and glycogenin: lessons from a search for genetic variability of the insulin-stimulated glycogen synthesis pathway of skeletal muscle in NIDDM patients: L Hansen, H Fjordvang, SK Rasmussen, H Vestergaard, SM Echwald, T Hansen, D Alessi, S Shenolikar, AR Saltiel, F Barbetti, and O Pedersen
Diabetes 1999 48: 403-407. [Abstract] [PDF]

A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland: T Otonkoski, C Ammala, H Huopio, GJ Cote, J Chapman, K Cosgrove, R Ashfield, E Huang, J Komulainen, FM Ashcroft, MJ Dunne, J Kere, and PM Thomas
Diabetes 1999 48: 408-415. [Abstract] [PDF]

Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the Japanese: I Iwata, S Nagafuchi, H Nakashima, S Kondo, T Koga, Y Yokogawa, T Akashi, T Shibuya, Y Umeno, T Okeda, S Shibata, S Kono, M Yasunami, H Ohkubo, and Y Niho
Diabetes 1999 48: 416-419. [Abstract] [PDF]

Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes: S Maeda, M Haneda, H Yasuda, T Tachikawa, K Isshiki, D Koya, M Terada, H Hidaka, A Kashiwagi, and R Kikkawa
Diabetes 1999 48: 420-422. [PDF]

Mutation in the HNF-4alpha gene affects insulin secretion and triglyceride metabolism: M Lehto, PO Bitzen, B Isomaa, C Wipemo, Y Wessman, C Forsblom, T Tuomi, MR Taskinen, and L Groop
Diabetes 1999 48: 423-425. [PDF]

Leptin promotes aggregation of human platelets via the long form of its receptor: M Nakata, T Yada, N Soejima, and I Maruyama
Diabetes 1999 48: 426-429. [Abstract] [PDF]

Streptozotocin treatment upregulates uncoupling protein 3 expression in the rat heart: S Hidaka, T Kakuma, H Yoshimatsu, H Sakino, S Fukuchi, and T Sakata
Diabetes 1999 48: 430-435. [Abstract] [PDF]

Post-starvation gene expression of skeletal muscle uncoupling protein 2 and uncoupling protein 3 in response to dietary fat levels and fatty acid composition: a link with insulin resistance: S Samec, J Seydoux, and AG Dulloo
Diabetes 1999 48: 436-441. [Abstract] [PDF]